Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-020025

BIOGEN INC. · BIIB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael D Ehlers
Officer — EVP, Research and Development
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 1, 2018F460$297.09D4,513D
Common StockJun 1, 2018M1,384$0.00A5,897D
Common StockJun 1, 2018F616$297.09D5,281D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF2$0.00Jun 1, 2018M1,384D—Jun 1, 2019Common Stock1,3843,612D
Restricted Stock UnitF3,F2$0.00Jun 1, 2018J1,110D—Jun 1, 2019Common Stock1,1102,502D

Explanation of responses